Bristol Abilify To Launch In Late November; Antipsychotic Approved Nov. 15
Bristol-Myers Squibb/Otsuka's Abilify (aripiprazole) will be launched by the end of November following FDA's Nov. 15 approval of the atypical antipsychotic
Bristol-Myers Squibb/Otsuka's Abilify (aripiprazole) will be launched by the end of November following FDA's Nov. 15 approval of the atypical antipsychotic